These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 21036746)

  • 1. Concordant analysis of KRAS status in primary colon carcinoma and matched metastasis.
    Mariani P; Lae M; Degeorges A; Cacheux W; Lappartient E; Margogne A; Pierga JY; Girre V; Mignot L; Falcou MC; Salmon RJ; Delattre O; De Cremoux P
    Anticancer Res; 2010 Oct; 30(10):4229-35. PubMed ID: 21036746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.
    Schmid K; Oehl N; Wrba F; Pirker R; Pirker C; Filipits M
    Clin Cancer Res; 2009 Jul; 15(14):4554-60. PubMed ID: 19584155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases.
    Baldus SE; Schaefer KL; Engers R; Hartleb D; Stoecklein NH; Gabbert HE
    Clin Cancer Res; 2010 Feb; 16(3):790-9. PubMed ID: 20103678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance in KRAS and BRAF mutations in endoscopic biopsy samples and resection specimens of colorectal adenocarcinoma.
    Krol LC; 't Hart NA; Methorst N; Knol AJ; Prinsen C; Boers JE
    Eur J Cancer; 2012 May; 48(7):1108-15. PubMed ID: 22446020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS mutation status in primary nonsmall cell lung cancer and matched metastases.
    Cortot AB; Italiano A; Burel-Vandenbos F; Martel-Planche G; Hainaut P
    Cancer; 2010 Jun; 116(11):2682-7. PubMed ID: 20336783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer.
    Artale S; Sartore-Bianchi A; Veronese SM; Gambi V; Sarnataro CS; Gambacorta M; Lauricella C; Siena S
    J Clin Oncol; 2008 Sep; 26(25):4217-9. PubMed ID: 18757341
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic and molecular diversity of colon cancer hepatic metastases.
    Messick CA; Sanchez J; Dejulius KL; Church JM; Kalady MF
    Surgery; 2009 Aug; 146(2):227-31. PubMed ID: 19628078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer.
    Bleeker WA; Hayes VM; Karrenbeld A; Hofstra RM; Hermans J; Buys CC; Plukker JT
    Am J Gastroenterol; 2000 Oct; 95(10):2953-7. PubMed ID: 11051374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The KRAS mutation detection within the initial management of patients with metastatic colorectal cancer: a status report in France in 2011.
    Lièvre A; Artru P; Guiu M; Laurent-Puig P; Merlin JL; Sabourin JC; Viguier J; Bastie A; Seronde A; Ducreux M
    Eur J Cancer; 2013 Jun; 49(9):2126-33. PubMed ID: 23473612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma.
    Kang S; Kim HS; Seo SS; Park SY; Sidransky D; Dong SM
    Gynecol Oncol; 2007 Jun; 105(3):662-6. PubMed ID: 17360030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications.
    Wu CC; Hsu HY; Liu HP; Chang JW; Chen YT; Hsieh WY; Hsieh JJ; Hsieh MS; Chen YR; Huang SF
    Cancer; 2008 Dec; 113(11):3199-208. PubMed ID: 18932251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.
    Schulten HJ; Al-Maghrabi J; Al-Ghamdi K; Salama S; Al-Muhayawi S; Chaudhary A; Hamour O; Abuzenadah A; Gari M; Al-Qahtani M
    Anticancer Res; 2011 Dec; 31(12):4179-83. PubMed ID: 22199277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas.
    Fransén K; Klintenäs M; Osterström A; Dimberg J; Monstein HJ; Söderkvist P
    Carcinogenesis; 2004 Apr; 25(4):527-33. PubMed ID: 14688025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
    Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
    Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status.
    Pappa KI; Choleza M; Markaki S; Giannikaki E; Kyroudi A; Vlachos G; Voulgaris Z; Anagnou NP
    Gynecol Oncol; 2006 Mar; 100(3):596-600. PubMed ID: 16256179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAS mutation status impacts diagnosis and treatment decision in a patient with two colon tumours: a case report.
    Li X; Pezeshkpour G; Phan RT
    J Clin Pathol; 2015 Jan; 68(1):83-5. PubMed ID: 25313410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the concordance in the EGFR pathway status between primary tumors and related metastases of colorectal cancer patients:implications for cancer therapy.
    Cejas P; López-Gómez M; Aguayo C; Madero R; Moreno-Rubio J; de Castro Carpeño J; Belda-Iniesta C; Barriuso J; Moreno García V; Díaz E; Burgos E; Gonzalez-Barón M; Feliu J
    Curr Cancer Drug Targets; 2012 Feb; 12(2):124-31. PubMed ID: 22229245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature review.
    Sherwood J; Dearden S; Ratcliffe M; Walker J
    J Exp Clin Cancer Res; 2015 Sep; 34(1):92. PubMed ID: 26338018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients.
    Knijn N; Mekenkamp LJ; Klomp M; Vink-Börger ME; Tol J; Teerenstra S; Meijer JW; Tebar M; Riemersma S; van Krieken JH; Punt CJ; Nagtegaal ID
    Br J Cancer; 2011 Mar; 104(6):1020-6. PubMed ID: 21364579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer.
    Kim MJ; Lee HS; Kim JH; Kim YJ; Kwon JH; Lee JO; Bang SM; Park KU; Kim DW; Kang SB; Kim JS; Lee JS; Lee KW
    BMC Cancer; 2012 Aug; 12():347. PubMed ID: 22876814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.